Stocks
FocalTherics Confirms 2026 HIFU Revenue, Secures $40M Equity
FocalTherics (FOCL) reiterates its $50M-$54M 2026 HIFU revenue outlook and successfully closes a $40M equity offering, signaling a transformative period for the...
FocalTherics (FOCL) reiterates its $50M-$54M 2026 HIFU revenue outlook and successfully closes a $40M equity offering, signaling a transformative period for the...